PROFESSIONAL EDITION

The largest community of pharma leaders

Talaris Therapeutics Adds Two Experienced Biotechnology Executives to its Board of Directors

BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to induce durable immune tolerance across a range of indications, today announced the appointment of Sapna Srivastava, Ph.D., and Gaurav Shah, M.D., as independent representatives to its Board of Directors. “Sapna and Gaurav are both experienced biotechnology leaders with deep industry knowledge and a track record of value
Source Read More

Recent Articles